DOI: 10.2337/db06-1135
ADIPOSE MITOCHONDRIAL BIOGENESIS IS SUPPRESSED IN DB/DB & HIGH-FAT DIET-FED MICE AND IMPROVED BY ROSIGLITAZONE ,,![]() ![]() ,![]() ![]() ![]()
*High Throughput Biology, Discovery Research Correspondence: james.x.rong{at}gsk.com
Objective:The objective of this study was to further establish and confirm the relationship of adipose mitochondrial biogenesis in diabetes/obesity and the effects of rosiglitazone (RSG), a PPAR Research Design & Methods:Using microarray technology, adipose mitochondrial gene transcription was studied in db/db, high-fat diet-fed C57BL/6 (HFD), and respective control mice with or without RSG treatment. The findings were extended using mitochondrial staining, DNA quantification, and measurements of citrate synthase activity.
Results:In db/db and HFD mice, gene transcripts associated with mitochondrial ATP production, energy uncoupling, mitochondrial ribosomal proteins, outer and inner membrane translocases, and mitochondrial heat-shock proteins were decreased in abundance, compared to db/+ and standard-fat diet-fed control mice, respectively. RSG dose-dependently increased these transcripts in both db/db and HFD mice, and induced transcription of mitochondrial structural proteins and cellular antioxidant enzymes, responsible for removal of reactive oxygen species generated by increased mitochondrial activity. Transcription factors, including PGC1ß, PGC1 Conclusions:Adipose mitochondrial biogenesis was overwhelmingly suppressed in both mouse models of diabetes/obesity and globally induced by RSG. These findings suggest an important role of adipose mitochondria in diabetes/obesity, and the potential for new treatment approaches targeting adipose mitochondria.
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||